BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released Feb 26, 2018, before the open
10-K filed Feb 26, 2018, 57 days after period end · 0001564590-18-003114
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $358.31M | $300.09M | $227.94M | $229.40M |
| Net Income | -$51.39M | -$90.72M |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| $68.62M |
| -$69.80M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.